Loading...
XSHG
688399
, Last price  
Name

Jiangsu Bioperfectus Technologies Co Ltd

Chart & performance

D1W1MN
XSHG:688399 chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
-0.53%
Rev. 5Y
-27.84%
Div Yld LY
—
Div Yld TTM
—
Revenues
340m
-2.64%
129,141,955187,286,184230,700,329288,794,7091,739,680,7012,839,036,3425,534,792,783403,179,296349,608,940340,380,400
Net income
-41m
L+1,952.18%
8,360,84142,668,44963,824,57383,756,181819,567,3441,193,214,2631,827,900,392-373,811,354-2,001,694-41,078,454
CFO
30m
-79.21%
22,093,26261,591,07485,818,827106,718,818935,881,451985,522,9251,964,878,0810145,925,31130,341,197
Dividend
Sep 11, 20255.032 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
URL
https://www.bioperfectus.com/
IPO date
Dec 05, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT